CN102319295B - 一种治疗上呼吸道感染的药剂 - Google Patents
一种治疗上呼吸道感染的药剂 Download PDFInfo
- Publication number
- CN102319295B CN102319295B CN2011102848774A CN201110284877A CN102319295B CN 102319295 B CN102319295 B CN 102319295B CN 2011102848774 A CN2011102848774 A CN 2011102848774A CN 201110284877 A CN201110284877 A CN 201110284877A CN 102319295 B CN102319295 B CN 102319295B
- Authority
- CN
- China
- Prior art keywords
- respiratory tract
- medicament
- upper respiratory
- tract infection
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 206010057190 Respiratory tract infections Diseases 0.000 title claims abstract description 15
- 206010046306 Upper respiratory tract infection Diseases 0.000 title claims abstract description 15
- 241000555682 Forsythia x intermedia Species 0.000 claims abstract description 3
- 239000010231 banlangen Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims 1
- 230000002924 anti-infective effect Effects 0.000 abstract description 2
- 230000000840 anti-viral effect Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 240000006851 Duhaldea cappa Species 0.000 abstract 1
- 241000893564 Dysosma pleiantha Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 241000691155 Pteris multifida Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 6
- 241000700605 Viruses Species 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 201000005180 acute myocarditis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种治疗上呼吸道感染的药剂，它是由下列原料药按重量份计制成：羊耳菊、凤尾草、连翘、八角莲、甘草、山豆根和板蓝根。本发明所述的治疗上呼吸道感染的药剂应用于治疗上呼吸道感染、具有解热镇痛、抗病毒、抗感染的作用。
Description
技术领域
本发明涉及医药领域，具体地说，涉及一种治疗上呼吸道感染的药剂。
背景技术
上呼吸道感染是指自鼻腔至喉部之间的急性炎症的总称，是最常见的感染性疾病。90％左右由病毒引起，细菌感染常继发于病毒感染之后。该病四季、任何年龄均可发病，通过含有病毒的飞沫、雾滴，或经污染的用具进行传播。常于机体抵抗力降低时，如受寒、劳累、淋雨等情况，原已存在或由外界侵入的病毒或/和细菌，迅速生长繁殖，导致感染。该病预后良好，有自限性，一般5-7天痊愈。常继发支气管炎、肺炎、副鼻窦炎，少数人可并发急性心肌炎、肾炎、风湿热等。
发明内容
本发明的目的是提供一种治疗上呼吸道感染的药剂。
为了实现本发明的目的，本发明提供一种治疗上呼吸道感染的药剂，它是由下列原料药按重量份计制成：羊耳菊5-10份、凤尾草20-40份、连翘10-30份、八角莲20-50份、甘草5-15份、山豆根10-30份和板蓝根5-10份。
优选地，它是由下列原料药按重量份计制成：羊耳菊8份、凤尾草30份、连翘20份、八角莲30份、甘草10份、山豆根20份和板蓝根10份。
优选地，所述药剂为片剂、分散片、胶囊剂或软胶囊。
本发明所述的治疗上呼吸道感染的药剂应用于治疗上呼吸道感染、具有解热镇痛、抗病毒、抗感染的作用。
具体实施方式
以下通过具体实施方式的描述对本发明作进一步说明，但这并非是对本发明的限制，本领域技术人员根据本发明的基本思想，可以做出各种修改或改进，但是只要不脱离本发明的基本思想，均在本发明的范围之内。
实施例1本发明片剂的制备
取羊耳菊80克、凤尾草300克、连翘200克、八角莲300克、甘草100克、山豆根200克、板蓝根100克，粉碎，过80目筛。然后称取糖粉500克，过80目筛，和上述原料药混合。用3重量％的HPMC水溶液作粘合剂制软材，制粒(用16目尼龙筛制粒二遍)，在60℃下干燥2-3个小时，用16目的尼龙筛整粒。再加入400克的羧甲基淀粉钠和10克的硬脂酸镁，混匀，用直径14mm的冲头压片1000片。
实验例
诊断标准：上呼吸道感染西医诊断标准(陈颧珠主编，《实用内科学》第10版，人民卫生出版社)。感冒风热证中医诊断标准(张伯臾主编，中医内科学，第5版、上海科学技术出版社)。主症：咽痛、咽粘膜充血、口渴、微恶风寒。次症：头痛、鼻塞流涕、咳嗽、发热。舌苔薄白微黄或微黄，脉象浮数或滑数。
选择50例上呼吸道感染患者，男25例、女25例，平均年龄为37岁。
使用实施例1中制得的片剂来进行治疗，其中一天2次，每次一袋，治疗5天为一个疗程。
根据全国高等医药院校教材《内科学》来制定疗效标准。观察指标主要症状及体征：发热、咽痛、咳嗽、喘息、肺部罗音。辅助检查：白细胞及双肺正位片。
疗效判断标准痊愈：临床症状及体征消失，辅助检查恢复正常。有效：临床症状及体征消失或明显改善，辅助检查有一项正常者。无效：临床症状及体征无明显改善或临床出现并发症，辅助检查无改变。
经过有一个疗程的观察，50例患者的临床症状全部消失，并且在整个治疗期间未观察到明显的不良反应。
Claims (2)
1.一种治疗上呼吸道感染的药剂，其特征在于，它是由下列原料药按重量份计制成：羊耳菊8份、凤尾草30份、连翘20份、八角莲30份、甘草10份、山豆根20份和板蓝根10份。
2.根据权利要求1所述的治疗上呼吸道感染的药剂，其特征在于，所述药剂为片剂、散剂或软胶囊。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102848774A CN102319295B (zh) | 2011-09-23 | 2011-09-23 | 一种治疗上呼吸道感染的药剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102848774A CN102319295B (zh) | 2011-09-23 | 2011-09-23 | 一种治疗上呼吸道感染的药剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102319295A CN102319295A (zh) | 2012-01-18 |
| CN102319295B true CN102319295B (zh) | 2012-11-28 |
Family
ID=45447220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102848774A Expired - Fee Related CN102319295B (zh) | 2011-09-23 | 2011-09-23 | 一种治疗上呼吸道感染的药剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102319295B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751515A (zh) * | 2014-01-06 | 2014-04-30 | 崔磊 | 一种治疗上呼吸道感染的药物组合物 |
| CN106110255A (zh) * | 2016-07-22 | 2016-11-16 | 铜陵宏正网络科技有限公司 | 一种治疗上呼吸道感染的药剂 |
| CN107184845A (zh) * | 2017-06-12 | 2017-09-22 | 肖厥明 | 一种治疗上呼吸道感染的儿科鼻腔用药及其制备方法 |
-
2011
- 2011-09-23 CN CN2011102848774A patent/CN102319295B/zh not_active Expired - Fee Related
Non-Patent Citations (5)
| Title |
|---|
| 刘京京.甘草单用不好使.《农村医药报》.2007,20017年12月28日第A04版,第5段. |
| 南京中医药大学编著.白牛胆、凤尾草、连翘.《中药大辞典第二版》.上海科学技术出版社,2006,第677－679页、970-971页、1552-1555页. * |
| 甘草单用不好使;刘京京;《农村医药报》;20071228;20017年12月28日第A04版,第5段 * |
| 简便方治疗咽喉肿痛;韦麟;《民族医药报》;20040528;2004年05月28日第002版，第11段 * |
| 韦麟.简便方治疗咽喉肿痛.《民族医药报》.2004,2004年05月28日第002版，第11段. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102319295A (zh) | 2012-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101700307A (zh) | 一种治疗慢性咽喉炎的中药 | |
| CN102319295B (zh) | 一种治疗上呼吸道感染的药剂 | |
| CN102416098B (zh) | 一种治疗上呼吸道感染的药剂 | |
| CN104208473A (zh) | 一种治疗风热型咳喘疾病的中药组合物及其用途 | |
| CN103432506B (zh) | 一种治疗上呼吸道感染的药物组合物 | |
| CN103585360A (zh) | 一种治疗上呼吸道感染的中药制剂 | |
| CN104127542B (zh) | 一种治疗小儿反复上呼吸道感染的药物组合物 | |
| CN102973875B (zh) | 一种用于小儿健脾止泻消积的药剂 | |
| CN103933343B (zh) | 一种治疗支气管哮喘的中药药丸 | |
| CN102670856B (zh) | 一种治疗骨折的药剂 | |
| CN103721068B (zh) | 一种治疗小儿厌食症的药剂 | |
| CN102451254B (zh) | 一种治疗肺气肿的药物 | |
| CN103110918B (zh) | 一种治疗上呼吸道感染的药物 | |
| CN103230441A (zh) | 一种药物组合物、制剂及其用途 | |
| TOSHIKHANE et al. | Effect of Ayurvedic Management in Covid-19 Pneumonia: A Series of Two Cases. | |
| CN102406747A (zh) | 一种治疗小儿上呼吸道感染的中药组合物 | |
| CN108653552B (zh) | 一种清肺止咳中药 | |
| Gayatri et al. | A CASE REPORT TREATMENT OF SARS CoV-2 WITH CLASSICAL SIDDHA MEDICINE | |
| CN106309727A (zh) | 一种防治肾虚血瘀型2型糖尿病认知功能障碍的中药组合物 | |
| CN105999121A (zh) | 一种治疗慢性支气管炎的中药汤剂 | |
| CN106031781A (zh) | 一组治疗小儿哮喘的中药组合物 | |
| CN105687269A (zh) | 一种穿心莲提取物及衍生物注射剂制备洗鼻液的方法 | |
| CN104138413A (zh) | 一种治疗小儿流感的药物组合物 | |
| Nie et al. | The Comparative Study on Two Models of Syndrome Differentiation of the Hand, Foot and Mouth Disease: An Investigation Analysis of the Signs and Symptoms on 2325 Cases | |
| CN102784167B (zh) | 一种治疗病毒性肺炎的药物组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: TIANJIANG PHARMACEUTICAL INDUSTRY CO., LTD., JIANG Free format text: FORMER OWNER: ZHU LAIQING Effective date: 20130716 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272100 JINING, SHANDONG PROVINCE TO: 214400 WUXI, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130716 Address after: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8 Patentee after: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin Address before: 272100 Department of pharmacy, first people's Hospital, 6 health Road, Shandong, Jining Patentee before: Zhu Laiqing |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170419 Address after: Wan Zhuang Langfang city of Hebei Province, 065006 oil base oil four factory Guangyang District 3 Building 1 unit 3 room Patentee after: Wang Chunfang Address before: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8 Patentee before: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin |
|
| CP02 | Change in the address of a patent holder | ||
| CP02 | Change in the address of a patent holder |
Address after: 266700 Shandong city of Qingdao Province Pingdu liaolan Town Road No. 2. Patentee after: Wang Chunfang Address before: Wan Zhuang Langfang city of Hebei Province, 065006 oil base oil four factory Guangyang District 3 Building 1 unit 3 room Patentee before: Wang Chunfang |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121128 Termination date: 20170923 |